Healthcare
OrthoPediatrics Corp.(KIDS)
Live Price
Offline$18.51
-1.91% today
1Y Change
-13.32%
Window
Jun 26, 2025 โ Jun 18, 2026
- Market Cap
- $390.00M
- Revenue Growth
- +15.4%
- EPS Growth
- -3.0%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 26, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
OrthoPediatrics Corp. (KIDS) is a Healthcare stock with a market cap of $390.00M and listed on NASDAQ. The stock last traded around $18.51 and down 13.3% across the available one-year price window (Jun 26, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +15.4%, EPS growth of -3.0%, a dividend yield of 0.0%. What stands out right now is revenue +15.4%, EPS -3.0%, free cash flow +61.4% with operating margin -10.8% and ROIC -5.8%. Valuation is more restrained than many high-expectation growth names at price/sales 1.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines KIDS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+15.4% vs +7.6% peer median
Operating Margin
Below sector median
-10.8% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +15.4% and EPS is at -3.0%, with operating margin around -10.8%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.7% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | +2.6% | +3.9% | +5.7% |
2026 Feb 26, 2026 | +29.7% | +7.8% | +0.2% | -8.1% |
2025 Oct 28, 2025 | +7.7% | -2.7% | -2.0% | +12.9% |
Benchmark Edge
KIDS vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
KIDS
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
KIDS Max Drawdown
-38.18%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for KIDS and SPY.
Company Overview
OrthoPediatrics Corp.
NASDAQ Global Market
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
- Leadership
- David R. Bailey
- IPO Date
- Oct 13, 2017
- Employees
- 562
- Street Address
- 2850 Frontier Drive
- Mailing
- Warsaw, IN, 46582
- Region
- Warsaw, IN, US
- Reporting Currency
- USD
- Investor Line
- 574 268 6379
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 1.6
- Price/Book
- 1.1
Growth
- Revenue
- +15.4%
- EPS
- -3.0%
- Free Cash Flow
- +61.4%
Profitability
- Gross Margin
- 73.1%
- Operating Margin
- -10.8%
- Net Margin
- -16.3%
- ROE
- -11.4%
- ROIC
- -5.8%
Balance Sheet
- Debt/Equity
- 0.14
- Current Ratio
- 5.21
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.